Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 806 participants.
Also called NCT02651428
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 806 participants
- Sponsor
- Registry
-
NCT02651428
-
- Other papers using this trial's data
- Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02651428. Randomized; triple masking; primary purpose prevention. Start 2015-12 (registry gives no type); primary completion 2018-10 (actual). Results posted on 2021-08-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
- Condition
- Kidney Failure, Chronic
- Condition
- Catheter-Related Infections
- Intervention (Drug)
- Neutrolin
- Intervention (Drug)
- Heparin
- Lead sponsor
- CorMedix Therapeutics
- Collaborator
- PPD Development, LP
- Collaborator
- JMI Laboratories
- Collaborator
- Spectra Clinical Research
- Collaborator
- Davita Clinical Research
- Collaborator
- Frenova Renal Research
Record details
- Record id
cardio:ct-nct02651428- Content hash
3d19ce874dc7c18da9ef382157cecb83e821210c4dfd04254263a7c916871b97